BACKGROUND: Data about the genotype-specific human papillomavirus (HPV) prevalence in the Czech Republic is limited. We aimed to evaluate the prevalence and concordance of genotype-specific HPV infection detected in semen samples, penile swabs and cervical swabs from non-vaccinated heterosexual couples without HPV-associated disease. METHODS: Semen samples and penile swabs were collected from male partners and cervical swabs were collected from female partners of heterosexual couples treated for infertility (n = 195). Presence of HPV DNA in semen samples and cervical swabs was analyzed using the cobas® HPV Test and PapilloCheck®. Only the PapilloCheck® test was used to detect HPV in penile swabs. The genotype-specific prevalence and concordance of HPV infection not targeted by vaccine were evaluated using Fisher exact test. RESULTS: Both partners were infected with any HPV type in 13.8% (27/195) of couples and, of these couples, 55.6% (15/27) harbored at least one mutual genotype. High-risk HPV (hrHPV) genotypes were detected in 12.3% (24/195) of semen samples, 31.3% (61/195) of penile swabs, and 19.5% (38/195) of cervical swabs (P < 0.001). The most prevalent hrHPV genotype were HPV53 (2.56%; 5/195) in semen samples, HPV16 (6.67%, 13/195) in penile swabs and HPV39 (3.59%, 7/195) in cervical swabs. Low-risk (lrHPV) genotypes were detected in 5.13% (10/195) of semen samples, 15.9% (31/195) of penile swabs, and 4.10% (8/195) of cervical swabs (P < 0.001). Male sexual partners of HPV-positive women were more likely to be infected with at least one of the same HPV types than female sexual partners of HPV-positive men (34.9% vs. 17.9%, P = 0.055). CONCLUSIONS: This study showed that the detection of HPV infection differ by anatomic site and gender. Regardless the anatomic site, high prevalence of HPV genital infection was found in both Czech men and women.

Arleta IVF Ltd Komenskeho 702 517 41 Kostelec nad Orlici Czech Republic

Fertimed Ltd Boleslavova 2 776 00 Olomouc Czech Republic

Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University Olomouc Hnevotinska 1333 5 779 00 Olomouc Czech Republic

SpermBank International Katerinska 13 779 00 Olomouc Czech Republic

Zobrazit více v PubMed

Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:14–26. doi: 10.1016/j.bpobgyn.2017.08.006. PubMed DOI

Giuliano AR, Harris R, Sedjo RL, Baldwin S, Roe D, Papenfuss MR, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis. 2002;186(4):462–469. doi: 10.1086/341782. PubMed DOI

Trottier H, Mahmud S, Prado JC, Sobrinho JS, Costa MC, Rohan TE, et al. Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis. 2008;197(10):1436–1447. doi: 10.1086/587698. PubMed DOI PMC

Gao G, Smith DI. Human papillomavirus and the development of different cancers. Cytogenet Genome Res. 2016;150(3–4):185–193. doi: 10.1159/000458166. PubMed DOI

Jaworek H, Koudelakova V, Drabek J, Vrbkova J, Zborilova B, Oborna I, et al. A head-to-head analytical comparison of cobas 4800 HPV, PapilloCheck HPV Screening, and LMNX Genotyping Kit HPV GP for Detection of Human Papillomavirus DNA in Cervical and Cervicovaginal Swabs. J Mol Diagn. 2018;20(6):849–858. doi: 10.1016/j.jmoldx.2018.07.004. PubMed DOI

Jaworek H, Zborilova B, Koudelakova V, Brezinova J, Vrbkova J, Oborna I, et al. Prevalence of human papillomavirus infection in oocyte donors and women treated for infertility: an observational laboratory-based study. Eur J Obstet Gynecol Reprod Biol X. 2019;4:100068. doi: 10.1016/j.eurox.2019.100068. PubMed DOI PMC

Tachezy R, Smahelova J, Kaspirkova J, Salakova M. Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women. PLoS ONE. 2013;8(11):e79156. doi: 10.1371/journal.pone.0079156. PubMed DOI PMC

Tachezy R, Hamsikova E, Hajek T, Mikyskova I, Smahel M, Van RM, et al. Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol. 1999;58(4):378–386. doi: 10.1002/(sici)1096-9071(199908)58:4<378::aid-jmv10>3.0.co;2-p. PubMed DOI

Rob F, Tachezy R, Pichlik T, Skapa P, Rob L, Hamsikova E, et al. Concordance of HPV-DNA in cervical dysplasia or genital warts in women and their monogamous long-term male partners. J Med Virol. 2017;89(9):1662–1670. doi: 10.1002/jmv.24824. PubMed DOI

Rob F, Tachezy R, Pichlik T, Rob L, Kruzicova Z, Hamsikova E, et al. High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys. Dermatol Ther. 2017 doi: 10.1111/dth.12435. PubMed DOI

Bruni L, Albero G, Serrano B, Mena M, Gómez D, Munoz J, et al. Human Papillomavirus and Related Diseases in Czech Republic. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). 2019. https://hpvcentre.net/statistics/reports/CZE.pdf. Accesed 25 Feb 2020.

GmbH RD. Cobas®HPV Test. Roche Molecular Systems Inc 2015. https://www.accessdata.fda.gov/cdrh_docs/pdf10/p100020s017c.pdf. Accesed 25 Feb 2020.

GmbH. PapilloCheck® high-risk. Greiner Bio-One 2016. https://www.gbo.com/fileadmin/user_upload/Downloads/IFU_Instructions_for_Use/IFU_Diagnostics/PapilloCheck/IFU_PapilloCheck_E_BQ-013-09.pdf. Accesed 25 Feb 2020.

BV. LMNX kit HPV GP HR. Diassay 2014.

Reiter PL, Pendergraft WF, III, Brewer NT. Meta-analysis of human papillomavirus infection concordance. Cancer Epidemiol Biomarkers Prev. 2010;19(11):2916–2931. doi: 10.1158/1055-9965.EPI-10-0576. PubMed DOI PMC

Burchell AN, Richardson H, Mahmud SM, Trottier H, Tellier PP, Hanley J, et al. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol. 2006;163(6):534–543. doi: 10.1093/aje/kwj077. PubMed DOI

Widdice L, Ma Y, Jonte J, Farhat S, Breland D, Shiboski S, et al. Concordance and transmission of human papillomavirus within heterosexual couples observed over short intervals. J Infect Dis. 2013;207(8):1286–1294. doi: 10.1093/infdis/jit018. PubMed DOI PMC

Nyitray AG, Menezes L, Lu B, Lin HY, Smith D, Abrahamsen M, et al. Genital human papillomavirus (HPV) concordance in heterosexual couples. J Infect Dis. 2012;206(2):202–211. doi: 10.1093/infdis/jis327. PubMed DOI PMC

Hernandez BY, Wilkens LR, Zhu X, Thompson P, McDuffie K, Shvetsov YB, et al. Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis. 2008;14(6):888–894. doi: 10.3201/eid1406.070616. PubMed DOI PMC

Giuliano AR, Lee JH, Fulp W, Villa LL, Lazcano E, Papenfuss MR, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet. 2011;377(9769):932–940. doi: 10.1016/S0140-6736(10)62342-2. PubMed DOI PMC

Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis. 2006;194(8):1044–1057. doi: 10.1086/507432. PubMed DOI

Giuliano AR, Lazcano-Ponce E, Villa LL, Flores R, Salmeron J, Lee JH, et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2036–2043. doi: 10.1158/1055-9965.EPI-08-0151. PubMed DOI PMC

Rodriguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst. 2010;102(5):315–324. doi: 10.1093/jnci/djq001. PubMed DOI PMC

Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, De SS. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789–1799. doi: 10.1086/657321. PubMed DOI

Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, et al. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015;136(12):2752–2760. doi: 10.1002/ijc.29082. PubMed DOI PMC

Perino A, Giovannelli L, Schillaci R, Ruvolo G, Fiorentino FP, Alimondi P, et al. Human papillomavirus infection in couples undergoing in vitro fertilization procedures: impact on reproductive outcomes. Fertil Steril. 2011;95(5):1845–1848. doi: 10.1016/j.fertnstert.2010.11.047. PubMed DOI

Spandorfer SD, Bongiovanni AM, Fasioulotis S, Rosenwaks Z, Ledger WJ, Witkin SS. Prevalence of cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome. Fertil Steril. 2006;86(3):765–767. doi: 10.1016/j.fertnstert.2006.01.051. PubMed DOI

Lyu Z, Feng X, Li N, Zhao W, Wei L, Chen Y, et al. Human papillomavirus in semen and the risk for male infertility: a systematic review and meta-analysis. BMC Infect Dis. 2017;17(1):714. doi: 10.1186/s12879-017-2812-z. PubMed DOI PMC

Burden of HPV-induced diseases and cost effectiveness of catch-up vaccination in Czech Republic: a model-based study

Direct mailing of HPV self-sampling kits to women aged 50-65 non-participating in cervical screening in the Czech Republic